Eagle Pharmaceuticals Inc sell Piper Sandler
Start price
09.08.23
/
50%
€17.90
Target price
09.08.24
-
Performance (%)
-79.55%
End price
10.08.24
€3.66
Summary
This prediction ended on 10.08.24 with a price of €3.66. Piper_Sandler correctly predicted massive losses of -79.55% for Eagle Pharmaceuticals Inc. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Eagle Pharmaceuticals Inc | - | - | - |
| iShares Core DAX® | 4,24 % | 2,86 % | 14,03 % |
| iShares Nasdaq 100 | 4,89 % | 2,81 % | 32,71 % |
| iShares Nikkei 225® | 9,40 % | 7,83 % | 48,30 % |
| iShares S&P 500 | 3,53 % | 1,95 % | 25,25 % |
Comments by Piper_Sandler for this prediction
In the thread Eagle Pharmaceuticals Inc diskutieren
Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) was downgraded by analysts at Piper Sandler from a "neutral" rating to an "underweight" rating.
Ratings data for EGRX provided by MarketBeat
In the thread Trading Eagle Pharmaceuticals Inc
Die von Piper_Sandler gewählte maximale Laufzeit wurde überschritten